RAD001 Plus Carboplatin in Breast Cancer Patients

NCT01127763 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: RAD001
DRUG: Carboplatin

Sponsor

NYU Langone Health

Collaborators

[object Object]